$CSTL
CASTLE BIOSCIENCES INC

2020 Q2 Form 10-Q Financial Statement

#000144736220000169 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $12.72M $10.74M $8.717M
YoY Change 18.4% 169.89% 138.23%
Cost Of Revenue $2.146M $1.993M $1.598M
YoY Change 7.68% 50.21% 27.84%
Gross Profit $10.57M $8.746M $7.119M
YoY Change 20.84% 229.79% 195.89%
Gross Profit Margin 83.12% 81.44% 81.67%
Selling, General & Admin $10.39M $6.821M $6.047M
YoY Change 52.35% 63.98% 43.98%
% of Gross Profit 98.33% 77.99% 84.94%
Research & Development $2.704M $1.317M $1.394M
YoY Change 105.32% 13.61% 10.63%
% of Gross Profit 25.58% 15.06% 19.58%
Depreciation & Amortization $102.0K $86.00K $77.00K
YoY Change 18.6% 20.99% -3.75%
% of Gross Profit 0.97% 0.98% 1.08%
Operating Expenses $13.10M $8.138M $7.441M
YoY Change 60.92% 53.0% 35.54%
Operating Profit -$645.0K $608.0K -$322.0K
YoY Change -206.09% -122.8% -89.56%
Interest Expense $769.0K $1.693M $1.024M
YoY Change -54.58% 222.57% -296.92%
% of Operating Profit 278.45%
Other Income/Expense, Net $0.00 -$189.0K -$33.00K
YoY Change -100.0% -655.26% 65.0%
Pretax Income -$1.380M -$1.270M -$1.360M
YoY Change 8.66% -59.68% -62.53%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.376M -$1.269M -$1.358M
YoY Change 8.43% -59.78% -62.59%
Net Earnings / Revenue -10.82% -11.82% -15.58%
Basic Earnings Per Share -$0.08 -$1.05 -$1.22
Diluted Earnings Per Share -$0.08 -$1.05 -$1.22
COMMON SHARES
Basic Shares Outstanding 17.54M shares 2.153M shares 1.917M shares
Diluted Shares Outstanding 17.54M shares 2.153M shares 1.917M shares

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $179.8M $17.50M $16.20M
YoY Change 927.43%
Cash & Equivalents $179.8M $17.47M $16.23M
Short-Term Investments
Other Short-Term Assets $1.700M $800.0K $700.0K
YoY Change 112.5%
Inventory $1.667M $550.9K $800.0K
Prepaid Expenses
Receivables $12.53M $9.730M $9.200M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $195.7M $28.52M $27.00M
YoY Change 585.97%
LONG-TERM ASSETS
Property, Plant & Equipment $5.024M $1.743M $1.700M
YoY Change 188.21%
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $199.0K $1.813M $700.0K
YoY Change -89.03%
Total Long-Term Assets $5.875M $4.823M $4.000M
YoY Change 21.82%
TOTAL ASSETS
Total Short-Term Assets $195.7M $28.52M $27.00M
Total Long-Term Assets $5.875M $4.823M $4.000M
Total Assets $201.5M $33.35M $31.00M
YoY Change 504.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.495M $2.085M $1.600M
YoY Change 19.67%
Accrued Expenses $7.300M $4.400M $3.800M
YoY Change 65.91%
Deferred Revenue $8.350M
YoY Change
Short-Term Debt $0.00 $4.426M $3.600M
YoY Change -100.0%
Long-Term Debt Due $10.00M $833.3K
YoY Change 1100.0%
Total Short-Term Liabilities $28.24M $11.75M $9.000M
YoY Change 140.45%
LONG-TERM LIABILITIES
Long-Term Debt $14.74M $23.86M $23.60M
YoY Change -38.22%
Other Long-Term Liabilities $900.0K $1.300M $1.200M
YoY Change -30.77%
Total Long-Term Liabilities $14.74M $23.86M $24.80M
YoY Change -38.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.24M $11.75M $9.000M
Total Long-Term Liabilities $14.74M $23.86M $24.80M
Total Liabilities $43.92M $36.94M $33.80M
YoY Change 18.9%
SHAREHOLDERS EQUITY
Retained Earnings -$53.02M -$60.10M
YoY Change -11.78%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $157.6M -$50.20M -$49.43M
YoY Change
Total Liabilities & Shareholders Equity $201.5M $33.35M $31.00M
YoY Change 504.39%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$1.376M -$1.269M -$1.358M
YoY Change 8.43% -59.78% -62.59%
Depreciation, Depletion And Amortization $102.0K $86.00K $77.00K
YoY Change 18.6% 20.99% -3.75%
Cash From Operating Activities $13.50M $480.0K $1.288M
YoY Change 2712.5% -110.21% -151.31%
INVESTING ACTIVITIES
Capital Expenditures -$1.760M -$180.0K $244.0K
YoY Change 877.78% 20.0% -913.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.760M -$180.0K -$244.0K
YoY Change 877.78% 20.0% 713.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 69.36M 930.0K $10.71M
YoY Change 7358.06% -84.58% 100.13%
NET CHANGE
Cash From Operating Activities 13.50M 480.0K $1.288M
Cash From Investing Activities -1.760M -180.0K -$244.0K
Cash From Financing Activities 69.36M 930.0K $10.71M
Net Change In Cash 81.10M 1.230M $11.75M
YoY Change 6493.5% 4.24% 318.19%
FREE CASH FLOW
Cash From Operating Activities $13.50M $480.0K $1.288M
Capital Expenditures -$1.760M -$180.0K $244.0K
Free Cash Flow $15.26M $660.0K $1.044M
YoY Change 2212.12% -114.51% -142.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001447362
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38984
dei Entity Registrant Name
EntityRegistrantName
CASTLE BIOSCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0701774
dei Entity Address Address Line1
EntityAddressAddressLine1
820 S. Friendswood Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 201
dei Entity Address City Or Town
EntityAddressCityOrTown
Friendswood
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77546
dei City Area Code
CityAreaCode
866
dei Local Phone Number
LocalPhoneNumber
788-9007
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Trading Symbol
TradingSymbol
CSTL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19682156 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
179759000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98845000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12528000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14648000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
1667000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
1237000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1717000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1951000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
195671000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
116681000 USD
CY2020Q2 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
652000 USD
CY2019Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
870000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5024000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2060000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
199000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
135000 USD
CY2020Q2 us-gaap Assets
Assets
201546000 USD
CY2019Q4 us-gaap Assets
Assets
119746000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2495000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1865000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4651000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5779000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8350000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2746000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1812000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
10000000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5833000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
28242000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15289000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14741000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19289000 USD
CY2020Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
941000 USD
CY2019Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
55000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
43924000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
34633000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2019Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19373869 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19373869 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17130907 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17130907 shares
CY2020Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
19000 USD
CY2019Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
17000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
210621000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
137308000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53018000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52212000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
157622000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
85113000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
201546000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
119746000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12715000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10739000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30133000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19456000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2146000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1993000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4537000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3591000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
10569000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
8746000 USD
us-gaap Gross Profit
GrossProfit
25596000 USD
us-gaap Gross Profit
GrossProfit
15865000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2704000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1317000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5617000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2711000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10392000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6821000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21470000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12868000 USD
CY2020Q2 us-gaap Other Operating Income
OtherOperatingIncome
1882000 USD
CY2019Q2 us-gaap Other Operating Income
OtherOperatingIncome
0 USD
us-gaap Other Operating Income
OtherOperatingIncome
1882000 USD
us-gaap Other Operating Income
OtherOperatingIncome
0 USD
CY2020Q2 cstl Operating Expenses Net Of Other Operating Income
OperatingExpensesNetOfOtherOperatingIncome
11214000 USD
CY2019Q2 cstl Operating Expenses Net Of Other Operating Income
OperatingExpensesNetOfOtherOperatingIncome
8138000 USD
cstl Operating Expenses Net Of Other Operating Income
OperatingExpensesNetOfOtherOperatingIncome
25205000 USD
cstl Operating Expenses Net Of Other Operating Income
OperatingExpensesNetOfOtherOperatingIncome
15579000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-645000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
608000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
391000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
286000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
38000 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
336000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
26000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
769000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
1693000 USD
us-gaap Interest Expense
InterestExpense
1533000 USD
us-gaap Interest Expense
InterestExpense
2717000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-189000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-222000 USD
CY2020Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-1376000 USD
CY2019Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-1269000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-806000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-2627000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1376000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1376000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-1269000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1269000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-806000 USD
us-gaap Net Income Loss
NetIncomeLoss
-806000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2627000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2627000 USD
CY2020Q2 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0 USD
CY2019Q2 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
939000 USD
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0 USD
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
1867000 USD
CY2020Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0 USD
CY2019Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
57000 USD
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0 USD
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
113000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1376000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2265000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-806000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4607000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.26
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.26
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17544000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2153000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17458000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2036000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17544000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2153000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17458000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2036000 shares
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-49433000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
139000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
416000 USD
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
8378000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2627000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-1269000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-50204000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
87934000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1653000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
330000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
69081000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1376000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
157622000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-56566000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
307000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
417000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-50204000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
85113000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3230000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
401000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
603000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
69081000 USD
us-gaap Net Income Loss
NetIncomeLoss
-806000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
157622000 USD
us-gaap Net Income Loss
NetIncomeLoss
-806000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2627000 USD
us-gaap Depreciation
Depreciation
193000 USD
us-gaap Depreciation
Depreciation
163000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3230000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
307000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
452000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1250000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
86000 USD
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
0 USD
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-136000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2337000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3625000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-234000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
99000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
430000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-331000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
62000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
11000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
444000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-524000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1127000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1786000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
8350000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
263000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
902000 USD
cstl Increase Decreasein Deferred Lease Liability
IncreaseDecreaseinDeferredLeaseLiability
172000 USD
cstl Increase Decreasein Deferred Lease Liability
IncreaseDecreaseinDeferredLeaseLiability
13000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13250000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1770000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2256000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
424000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2256000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-424000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
69530000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4756000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
11695000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
1776000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
833000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1791000 USD
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
0 USD
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
454000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
400000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
417000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
823000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
69920000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11643000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
80914000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12989000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98845000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4479000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
179759000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17468000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
194000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
12000 USD
cstl Property And Equipment Acquired With Tenant Improvement Allowance
PropertyAndEquipmentAcquiredWithTenantImprovementAllowance
714000 USD
cstl Property And Equipment Acquired With Tenant Improvement Allowance
PropertyAndEquipmentAcquiredWithTenantImprovementAllowance
0 USD
cstl Offering Costs And Debt Issuance Costs Incurred But Not Yet Paid
OfferingCostsAndDebtIssuanceCostsIncurredButNotYetPaid
451000 USD
cstl Offering Costs And Debt Issuance Costs Incurred But Not Yet Paid
OfferingCostsAndDebtIssuanceCostsIncurredButNotYetPaid
1205000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
179800000 USD
us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates include revenue recognition, the valuation of stock-based compensation, assessing future tax exposure and the realization of deferred tax assets, the useful lives and recoverability of property and equipment, and contingent liabilities. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and assumptions. The Company has considered the potential impact of the COVID-19 pandemic on its estimates and assumptions and while there was not a material impact to the Company’s condensed financial statements as of and for the three and six months ended June 30, 2020, the extent to which the COVID-19 pandemic may impact the Company’s estimates is uncertain and subject to change.
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
cstl Contract With Customer Customer Payment Terms
ContractWithCustomerCustomerPaymentTerms
P30D
CY2020Q2 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
2291000 USD
CY2019Q2 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
3257000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1048000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
2794000 USD
CY2020Q2 cstl Centers For Medicare And Medicaid Services Accelerated And Advanced Payment Program Payment Received
CentersForMedicareAndMedicaidServicesAcceleratedAndAdvancedPaymentProgramPaymentReceived
8300000 USD
CY2020Q2 cstl Accelerated And Advanced Payment Program Period After Payment Received Until Recoupment Is Required
AcceleratedAndAdvancedPaymentProgramPeriodAfterPaymentReceivedUntilRecoupmentIsRequired
P120D
CY2020Q2 cstl Accelerated And Advanced Payment Program Period For Payment To Be Fully Recouped
AcceleratedAndAdvancedPaymentProgramPeriodForPaymentToBeFullyRecouped
P210D
cstl Revenue From Contract With Customer Revenue Not Yet Recognized Number Of Claims In Adjudication Process
RevenueFromContractWithCustomerRevenueNotYetRecognizedNumberOfClaimsInAdjudicationProcess
2698 claim
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2020Q2 us-gaap Other Operating Income
OtherOperatingIncome
1900000 USD
CY2020Q2 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
3060000 USD
CY2019Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
4785000 USD
CY2020Q2 cstl Deferred Payroll Taxes Cares Act
DeferredPayrollTaxesCARESAct
176000 USD
CY2020Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2000000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2870000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11133000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2855000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10868000 shares
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6420000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3263000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1396000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1203000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5024000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2060000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
102000 USD
CY2019Q2 us-gaap Depreciation
Depreciation
86000 USD
us-gaap Depreciation
Depreciation
193000 USD
us-gaap Depreciation
Depreciation
163000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
184000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
79000 USD
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
97097 shares
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1883000 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1162000 USD
CY2020Q2 us-gaap Interest Payable Current
InterestPayableCurrent
172000 USD
CY2020Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
438000 USD
CY2019Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
218000 USD
CY2020Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
164000 USD
CY2019Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
169000 USD
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
79000 USD
CY2020Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
10000 USD
CY2019Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
0 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2746000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1812000 USD
cstl Offering Costs And Debt Issuance Costs Incurred But Not Yet Paid
OfferingCostsAndDebtIssuanceCostsIncurredButNotYetPaid
500000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
863127 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
856545 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
290120 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2637966 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
290120 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
33.04
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
202975 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
24850 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
24850 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
26.44
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1454402 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2700261 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.15
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M13D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
58172000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
628392 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y21D
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
22076000 USD
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.39
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1653000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
139000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3230000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
307000 USD

Files In Submission

Name View Source Status
0001447362-20-000169-index-headers.html Edgar Link pending
0001447362-20-000169-index.html Edgar Link pending
0001447362-20-000169.txt Edgar Link pending
0001447362-20-000169-xbrl.zip Edgar Link pending
cstl-20200630.htm Edgar Link pending
cstl-20200630.xsd Edgar Link pending
cstl-20200630_cal.xml Edgar Link unprocessable
cstl-20200630_def.xml Edgar Link unprocessable
cstl-20200630_htm.xml Edgar Link completed
cstl-20200630_lab.xml Edgar Link unprocessable
cstl-20200630_pre.xml Edgar Link unprocessable
exhibit311-q22020.htm Edgar Link pending
exhibit312-q22020.htm Edgar Link pending
exhibit321-q22020.htm Edgar Link pending
exhibit322-q22020.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending